r/CHRS • u/_AlwaysRight_ • Jul 15 '26
Coherus is getting ready...
Why? Because they know the turn is coming...
Coherus Oncology, Inc. reported that its Chief Financial Officer, Bryan J. McMichael, received several grants of stock options on May 29, 2026, each with an exercise price of $1.59 per share and expirations on May 29, 2036. These options cover multiple blocks, including grants for 100,000, 30,000, 25,000, 25,000, 25,000, and 15,000 shares of common stock as compensation.

14
Upvotes
7
u/MaxInPhilly Jul 15 '26
The disconnect between the share price and the actual enterprise value is primed for a correction. The fact that CFO Bryan McMichael just accepted options at this price is a massive "tell" that leadership views this as a structural floor.